The Medical Letter on Drugs and Therapeutics
A Sumatriptan Patch (Zecuity) for Migraine
The full article is available to subscribers Subscriber Login   
Revised 11/24/2015: In the Zecuity introductory paragraph "serotonin receptor antagonists" has been changed to "serotonin 1B/1D-receptor agonists".

The FDA has approved a sumatriptan iontophoretic transdermal system (Zecuity – Teva) for acute treatment of migraine in adults. Sumatriptan, the first of seven serotonin 1B/1D-receptor agonists (triptans) approved for this indication, is the most frequently prescribed migraine treatment in the US. It is also available in oral, intranasal, and injectable formulations.

RATIONALE FOR A PATCH — Patients with migraine who also have nausea, vomiting, or gastroparesis may not be able to take or absorb an oral triptan. Nasal sprays have a more rapid onset of action than oral formulations (10-15 vs 30-60 minutes), but they can have an unpleasant taste and they also depend on gastrointestinal absorption of the significant portion of the dose that is swallowed. Subcutaneously administered sumatriptan is the fastest acting (about 10 minutes) and most effective triptan formulation, but it causes more ... more      

The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this article?  Gain access below.

Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Immediate Online access to current issue and archives from 1988 to the present
  • Mobile access to our mobile site and free apps for iOS, Android and Kindle
  • FREE online per issue CME/CE
Free trial offer
3 Free Issues of The Medical Letter on Drugs and Therapeutics mailed to your home or office PLUS online access.
Try a Free Trial Subscription
Purchase this article:
Title: A Sumatriptan Patch (Zecuity) for Migraine
Article code: 1481a
 Electronic, downloadable article - $25